HOME
Leading the way to a cure

Lupus Research Update: 2011 Volume 4

Volume 4, 2011 - Online Edition | In This Issue


Leading the Way to a Cure >
Research in Action: Clinical Trial Study Offers New Hope >
Understanding Lupus: Terminology and Processes >
Faces of Lupus: A Voice for Many >
10 Reasons Why Donor Support Remains Critical >
Lupus News Corner >

Leading the Way to a Cure

A Look at the Accomplishments of 2011

In its quest to find a cure for lupus, the Alliance for Lupus Research (ALR) has funded unparalleled scientific explorations in 2011 to expand the conceptual understanding of lupus and lead the way to new treatments, while inspiring scientists, pharmaceutical companies, and individuals to stop lupus in its tracks.

Finding Answers Through Research

Through its rigorous grant mechanisms, the ALR has awarded almost $6 million in 2011 to fund 32 innovative scientific studies. “The ALR is continuing to do what it does best,” said ALR President Kenneth M. Farber. “We give the world’s brightest and best researchers the means to investigate promising, novel ideas that otherwise might never get off the ground.”

Building on its major SLEGEN* Consortium breakthrough — which discovered the first lupus genetic markers — the ALR is now funding a new cutting-edge biomedical technology called the ImmunoChip*, which will study hundreds of thousands of genes and their variants in a large number of participants from different ethnicities.

Director of SLEGEN, Dr. Timothy Vyse, adds his perspective: “Among its many real and tangible benefits, ImmunoChip is giving us invaluable data on cross-ancestry comparisons. This technology has the potential to significantly open new pathways to a better understanding of the genetics behind the disease.”

Today, the number of biotech and pharmaceutical companies interested in fighting lupus has grown from a handful in 2000 to several dozen. In fact, many of the new therapies now in clinical trials have their origins in ALR-funded research.

Involving Everyone in the Quest

Moving outside of the realm of the lab, the ALR pushed lupus to the forefront of public awareness. The Walk with Us to Cure Lupus events — in 18 cities — brought together tens of thousands of volunteers and raised more than $2.5 million … the Boston Bruins, the Chicago Wolves, the Chicago Blackhawks, and the NY Jets have joined us to promote Lupus Awareness Day at major sporting venues across the country … and visitors to the ALR website were introduced to Voices of Lupus — a new podcast series that shares valuable information about the disease.

Since its inception, the ALR has been fighting lupus on many fronts — and funding pioneering research is paramount among them. With 159 grants awarded and more than $70 million committed to lupus research, the ALR is the world’s largest private funder of lupus research.

*For more information on SLEGEN & ImmunoChip, visit www.lupusresearch.org/research/slegen/



1.5 million

people in the U.S. have Lupus.

90 million

dollars committed to lupus research by the Alliance for Lupus Research.


We're walking across the United States to raise awareness and funds for lupus research.

Can't make it? Join our National Virtual Walk to participate anytime, anywhere.


Show your support by visiting the Alliance for Lupus Research online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.